Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048

CompletedOBSERVATIONAL
Enrollment

326

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 2000

Conditions
Mycobacterium Avium-intracellulare InfectionHIV InfectionsPneumococcal Infections
Trial Locations (15)

10037

Harlem AIDS Treatment Grp / Harlem Hosp Ctr, New York

19107

Philadelphia FIGHT, Philadelphia

20422

Washington Reg AIDS Prog / Dept of Infect Dis, Washington D.C.

23298

Richmond AIDS Consortium / Div of Infect Diseases, Richmond

30308

AIDS Research Consortium of Atlanta, Atlanta

48201

Wayne State Univ - WSU/DMC / Univ Hlth Ctr, Detroit

48202

Henry Ford Hosp, Detroit

60657

AIDS Research Alliance - Chicago, Chicago

70112

Louisiana Comm AIDS Rsch Prog / Tulane Univ Med, New Orleans

80204

Denver CPCRA / Denver Public Hlth, Denver

87131

Partners in Research / New Mexico, Albuquerque

94110

Community Consortium / UCSF, San Francisco

97210

The Research and Education Group, Portland

08103

Southern New Jersey AIDS Cln Trials / Dept of Med, Camden

07103

North Jersey Community Research Initiative, Newark

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000933 - Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048 | Biotech Hunter | Biotech Hunter